Huntsman Corp (HUN):企業の財務・戦略的SWOT分析

◆英語タイトル:Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15459
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Huntsman Corp (HUN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Huntsman Corp (Huntsman) is a manufacturer of differentiated organic chemical products. It offers a broad range of chemicals and formulations, including amines, surfactants, carbonates and maleic anhydride; methyl diphenyl diisocyanate-based polyurethanes; epoxy-based polymer formulations, textile chemicals and dyes. Huntsman sells its products to diverse range of consumer and industrial customers. Its products find application in a range of applications, including adhesives, aerospace, personal care and hygiene, automotive, construction products, durable and non-durable consumer products, digital inks, electronics, power generation, refining, medical, packaging, coatings and construction, synthetic fiber, textile chemicals and dyes industries. The company operates through a global network of administrative, research and development and manufacturing units in the US, China, Germany, Mexico and other countries. Huntsman is headquartered in Texas, the US.

Huntsman Corp Key Recent Developments

Mar 18,2019 Huntsman Updates First Quarter 2019 Outlook
Feb 27,2019 Huntsman appoints Vice Admiral Jan E. Tighe to its Board of Directors
Feb 12,2019 Huntsman Announces Record Full Year 2018 Earnings With Strong and Consistent Cash Flow

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Huntsman Corp – Key Facts
Huntsman Corp – Key Employees
Huntsman Corp – Key Employee Biographies
Huntsman Corp – Major Products and Services
Huntsman Corp – History
Huntsman Corp – Company Statement
Huntsman Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Huntsman Corp – Business Description
Business Segment: Advanced Materials
Overview
Performance
Key Stats
Business Segment: Germany
Performance
Business Segment: Mexico
Performance
Business Segment: Performance Products
Overview
Performance
Key Stats
Business Segment: Polyurethanes
Overview
Performance
Key Stats
Business Segment: Textile Effects
Overview
Performance
Key Stats
Geographical Segment: China
Performance
Geographical Segment: Other Nations
Performance
Geographical Segment: United States
Performance
R&D Overview
Huntsman Corp – Corporate Strategy
Huntsman Corp – SWOT Analysis
SWOT Analysis – Overview
Huntsman Corp – Strengths
Huntsman Corp – Weaknesses
Huntsman Corp – Opportunities
Huntsman Corp – Threats
Huntsman Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Petrochemicals Financial Deals and Alliances
Huntsman Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Huntsman Corp, Petrochemicals, Deals By Type, 2013 to YTD 2019
Huntsman Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 18, 2019: Huntsman updates first quarter 2019 outlook
Feb 27, 2019: Huntsman appoints Vice Admiral Jan E. Tighe to its Board of Directors
Feb 12, 2019: Huntsman Announces Record Full Year 2018 Earnings With Strong and Consistent Cash Flow
Feb 12, 2019: Huntsman announces record full year 2018 earnings with strong and consistent cash flow
Feb 04, 2019: Huntsman Democratizes Advanced Analytics Globally with TrendMiner to Improve Overall Operational Performance
Oct 30, 2018: Huntsman Announces Third Quarter 2018 Earnings, Reports Strong EBITDA Growth and Solid Free Cash Flow Generation
Oct 30, 2018: Huntsman announces third quarter 2018 earnings; reports strong EBITDA growth and solid free cash flow generation
Jul 31, 2018: Huntsman Announces Strong and Consistent Growth in Second Quarter 2018 Earnings
May 14, 2018: Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Huntsman Corp, Key Facts
Huntsman Corp, Key Employees
Huntsman Corp, Key Employee Biographies
Huntsman Corp, Major Products and Services
Huntsman Corp, History
Huntsman Corp, Other Locations
Huntsman Corp, Subsidiaries
Huntsman Corp, Joint Venture
Huntsman Corp, Key Competitors
Huntsman Corp, Ratios based on current share price
Huntsman Corp, Annual Ratios
Huntsman Corp, Annual Ratios (Cont...1)
Huntsman Corp, Annual Ratios (Cont...2)
Huntsman Corp, Interim Ratios
Huntsman Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Huntsman Corp, Petrochemicals, Deals By Type, 2013 to YTD 2019
Huntsman Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Huntsman Corp, Performance Chart (2014 - 2018)
Huntsman Corp, Ratio Charts
Huntsman Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Huntsman Corp, Petrochemicals, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Huntsman Corp (HUN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solvay Group:企業のM&A・事業提携・投資動向
    Solvay Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solvay Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • Maxwell Technologies Inc. (MXWL)-エネルギー分野:企業M&A・提携分析
    Summary Maxwell Technologies, Inc. (Maxwell) formerly Maxwell Laboratories, Inc., is a manufacturer of energy storage systems and power delivery solutions. The company develops, manufactures and markets energy storage and power delivery products for transportation and other applications. It also off …
  • Merit Medical Systems Inc (MMSI):医療機器:M&Aディール及び事業提携情報
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an equipment manufacturing company that deals with the production and distribution of engineered precision bearings and products. The company's industrial product portfolio include ball bearings, cam followers, collets and toolholders, pins, rollers, shafts …
  • Westside Corporation Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Westside Corporation Pty Ltd (Westside) is an oil and gas company that explores and produces coal seam gas. The company provides gas seam projects such as Paranui ATP 769P, Meridian SeamGas CSG fields, Tilbrook ATP 688P, and Mount Saint Martin ATP 688P, among others. It offers Paranui ATP 76 …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Thomson Reuters Corporation:企業の戦略・SWOT・財務情報
    Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report Summary Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Astellas Pharma Europe Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Astellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a manufacturer and distributor of drug products. The company provides pharmaceutical drugs in the areas of oncology, transplantation, urology, anti-infective, pain management and dermatology. It also provide …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • United Therapeutics Corp (UTHR)-医療機器分野:企業M&A・提携分析
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Kymab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kymab Ltd (Kymab) is a therapeutic antibody company that provides drug and vaccine development solutions. The company offers pipepline of assets in the therapeutic areas of immuno-oncology, inflammatory disease, haematology, and infectious diseases. Its pipeline products includes KY1003-Anti …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sinohydro Corporation Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Sinohydro Corporation Co., Ltd (Sinohydro), a subsidiary of China Hydropower Construction Group International Engineering Co., Ltd., is an engineering and construction company. Its portfolio of services includes general construction, engineering, procurement and construction (EPC), and inves …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆